FindTrial
Sign In

Effect of Phalatrikadi Kwatha and Triphaladi Kwatha in the management of Madhumeha

A clinical study of Madhumeha ( type 2 Diabetes mellitus) and its management with Phalatrikadi Kwatha and Triphaladi Kwatha

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019788
Enrollment
30
Registered
2019-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Triphaladi Kwatha: Triphaladi Kwatha will be prepared as described in Sharangdhar Samhita (Kashaya Kalpana) Dose 40Ml Twice a day for 6 Weeks Control Intervention1: PHALATRIKADI KWATHA:

Sponsors

Government Akhandanand Ayurved College Bhadra Ahmedabad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Classical signs and symptoms as per Samhita as like Prabhootavila Mutrata Mutra Madhurya etc and Diabetes Mellitus type 2 according to modern medicine FBS more than 126 mg per dl And PP2BS more than 200 mg per dl Newly selected DM patients and those who have not yet started Anti Diabetic Drugs

Exclusion criteria

Exclusion criteria: IDDM Emergency cases Patients having any systemic disease and complications Gestational Diabetes Diabetic Neuropathy Nephropathy and Retinopathy Carcinoma etc FBS more than 300 mg per dl and PP2BS more than 400 mg per dl

Design outcomes

Primary

MeasureTime frame
RESULT WILL BE ASSESSED ON THE BASIS OF SIGN AND SYMPTOMS OF MADHUMEHA TYPE 2 DMTimepoint: 6 Weeks—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactRadhika A Gurjar

Government akhandanand ayurved college Bhadra Ahmedabad

shaikhmustak542@gmail.com9824440708

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026